List of Excipients in API lamotrigine extended release
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing lamotrigine extended release
Detailed excipient profiles for lamotrigine extended release
Excipient focus: FERRIC OXIDE RED
lamotrigine extended release drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
lamotrigine extended release drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
lamotrigine extended release drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
lamotrigine extended release drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
lamotrigine extended release drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
lamotrigine extended release drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lamotrigine extended release drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
lamotrigine extended release drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID
lamotrigine extended release drug variants containing METHACRYLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing METHACRYLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
lamotrigine extended release drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
lamotrigine extended release drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lamotrigine extended release drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
lamotrigine extended release drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
lamotrigine extended release drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lamotrigine extended release drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
lamotrigine extended release drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| TruPharma LLC | lamotrigine extended release | 52817-240 |
| >Company | >Ingredient | >NDC |
lamotrigine extended release drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Par Health USA LLC | lamotrigine extended release | 49884-561 |
| Bryant Ranch Prepack | lamotrigine extended release | 63629-7020 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links